|
US2020338045A1
|
|
Isoindoline compositions and methods for treating neurodegenerative disease
|
|
BR112019023851A2
|
|
compounds, their pharmaceutical compositions and methods for treating neurodegenerative diseases
|
|
US2017049723A1
|
|
Isolated compounds from turmeric oil and methods of use
|
|
AU2015210852A1
|
|
Isoindoline compositions and methods for treating neurodegenerative disease
|
|
EP2747768A2
|
|
Compositions and methods for treating neurodegenerative disease
|
|
US2014378473A1
|
|
Compositions and methods for treating neurodegenerative disease
|
|
CN103458885A
|
|
Isolated compounds from turmeric oil and methods of use
|
|
WO2011106785A2
|
|
Methods of identifying agents effective to treat cognitive decline and diseases associated therewith
|
|
AU2010278711A1
|
|
Inhibitors of cognitive decline
|
|
CN105968022A
|
|
Inhibitors of cognitive decline
|
|
US2008193574A1
|
|
Inhibitors of cognitive decline
|
